TNFRSF9 and lung carcinoma: Unlike B16-SIY and MC38-AS models, we found that anti-4-1BB slightly reduced the frequency of CD73+ T cell infiltrates in the LLC1 lung cancer model, but failed to make alteration in MC38-HS, ID8 ovarian and 4T1 breast tumor models.